The Fatigue Severity Scale (FSS) is widely used to assess fatigue, not only in the context of multiple sclerosis-related fatigue, but also in many other medical conditions. Some polysomnographic studies have shown high FSS values in sleep-disordered patients without multiple sclerosis. The Modified Fatigue Impact Scale (MFIS) has increasingly been used in order to assess fatigue, but polysomnographic data investigating sleep-disordered patients are thus far unavailable. Moreover, the pathophysiological link between sleep architecture and fatigue measured with the MFIS and the FSS has not been previously investigated. Methods: This was a retrospective observational study (n = 410) with subgroups classified according to sleep diagnosis. The statistical analysis included nonparametric correlation between questionnaire results and polysomnographic data, age and sex, and univariate and multiple logistic regression. Results: The multiple logistic regression showed a significant relationship between FSS/ MFIS values and younger age and female sex. Moreover, there was a significant relationship between FSS values and number of arousals and between MFIS values and number of awakenings. Conclusion: Younger age, female sex, and high number of awakenings and arousals are predictive of fatigue in sleep-disordered patients. Further investigations are needed to find the pathophysiological explanation for these relationships.
Introduction
Fatigue is the most frequent symptom in multiple sclerosis (MS). 1 The Multiple Sclerosis Council defines MS related fatigue as a "subjective lack of physical and/or mental energy that is perceived by the individual or caregiver to interfere with usual and desired activities," 2 and has recommended evaluation with the 21-item Modified Fatigue Impact Scale (MFIS) to measure fatigue, 2 which is a smaller version of the 40-item Fatigue Impact Scale (FIS). Abbreviations: ahi, apnea/hypopnea index; NreM-3/4, non-rapid eye movement stage 3/4; PlMD, periodic limb movement disorder; rls, restless legs syndrome; seM, standard error of the mean; spO2% min, minimal desaturation; srBD, sleep-related breathing disorder; TiB, time in bed; TsT, total sleep time; F, female; M, male.
The International Classification of Sleep Disorders second edition (ICSD-2) mentions "exhaustion" as a minimal criterion of sleep apnea, 16 but in general there are no objective measurements to differentiate fatigue from exhaustion. Complaints of fatigue may be as important as those of sleepiness are to obstructive sleep apnea syndrome (OSAS) patients, 17 and consequently, continuous positive airway pressure (CPAP) improves fatigue substantially in OSAS patients. 18 (Interestingly, women suffering from OSAS appear to have complaints of fatigue more frequently than men with OSAS). 17 Hossain et al 19 24 .5, so as not to overlook treatable sleep disorders. 23 Two different sleep studies have shown a significant relationship between MS-related fatigue and sleep disorders, 22, 25 and, in the corresponding follow-up trials, medical sleep treatment led to an improvement of MS-related fatigue. 26, 27 Aside from the abovementioned studies, 10, 11, 19, 21 
Methods Patients
In this retrospective observational study, all consecutive patients who were admitted to the sleep laboratory of the Hanse-Klinikum, Stralsund, Germany between February 1, 2011 and January 31, 2012 were included.
Questionnaires
All patients admitted to the sleep laboratory completed the MFIS, FSS, ESS, and PSQI.
Polysomnography
Polysomnographic data were retrospectively analyzed. These whole-night measurements were made after an impedance test and a biosignal test over a period of 8 hours, comprising: C3/C4 electroencephalograph (EEG) electrodes to the contralateral mastoid electrode; ground electrode; electrooculogram on the ipsilateral mastoid electrode; bipolar chin electromyogram (EMG) of the muscle mentalis or muscle submentalis (according to biosignal testing and anatomical conditions); nasal airflow (pressure sensor); thoracic and abdominal breathing (piezoelectric measurement); position sensor; snoring signal; pulse oximetry; pulse, electrocardiogram; and bipolar two-point EMG electrodes on both anterior tibial muscles.
The polysomnograph readings were scored according to the criteria of Rechtschaffen and Kales, 30 Patients were divided for statistical reasons into different subgroups: (1) untreated SRBDs; (2) treated SRBDs (patients were treated with CPAP or bilevel therapy); (3) PLMD and RLS; (4) insomnia; (5) parasomnia; (6) other neurological diseases such as narcolepsy, hypersomnia, and MS (due to a low number of patients and small sample sizes, these patients 
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Fatigue in patients with sleep disorders were classified into one subgroup even though these diseases are quite different); and (7) patients admitted to the sleep laboratory for tiredness or sleepiness but without pathological findings in the medical sleep investigations (exclusion of a sleep disorder).
statistical analysis
The results were expressed as mean, SD, and range. Following an exploratory analysis of the data and after a (negative) check for normality of the underlying distributions, differences between subgroups with respect to MFIS, ESS, PSQI, and FSS were (univariately) analyzed using the Mann-Whitney U test. Spearman correlation coefficients were calculated to assess the relationship between questionnaire results, and polysomnographic parameters and age, and scatter plots were performed to demonstrate these relationships. We defined Spearman's rank correlations (Spearman's rho) as follows: for values between 0.9 and 1, the correlation is very strong; for values between 0.7 and 0.89, the correlation is strong; values between 0.5 and 0.69 show a moderate correlation; for values between 0.3 and 0.49, the correlation is moderate to low; and for values ,0.3, the correlation is weak and not important.
Patients were classified into subgroups by MFIS (MFIS greater versus less than or equal to MFIS mean) and FSS (FSS greater versus less than or equal to FSS mean) values. Afterwards, a logistic regression was performed in order to predict the outcome of these two dependent variables (greater versus less than or equal to FSS mean/MFIS mean) with age, sex, and polysomnographic parameters, including AHI, SpO2% min, sleep efficacy, NREM-3/4, number of awakenings, arousal index, and sleep latency, as predictor variables. This analysis was performed in two steps: first, a univariate analysis with all predictor variables; subsequently, all significant variables remained in the final model of multiple logistic. Odds ratios were calculated. Statistical significance was established at P , 0.05.
All tests should be understood as constituting exploratory data analysis, such that neither previous power calculations nor subsequent adjustments for multiple testing have been made. Analysis was performed with SPSS software (v19; IBM Corporation, Armonk, NY, USA).
Results

Demographics, polysomnographic data, and questionnaire results
In sum, 410 patients 20 to 86 years (290 men and 120 women) were investigated. Table 1 displays the demographic and  polysomnographic data and Table 2 shows the questionnaire results. Note the higher amount of deep sleep in treated srBD patients, which seems not to have an impact on MFis or Fss values. it must also be pointed out that PlMD/rls patients showed a high number of awakenings. Abbreviations: ahi, apnea/hypopnea index; MFIS, Modified Fatigue Impact Scale; Ms, multiple sclerosis; NreM-3/4, non-rapid eye movement sleep stage 3/4; PlMD, periodic limb movement disorder; rls, restless legs syndrome; spO2% min, minimal desaturation; srBD, sleep-related breathing disorder; TiB, time in bed; TsT, total sleep time; Fss, Fatigue severity scale. Table 3 shows the nonparametric correlations.
Nonparametric correlation
correlations between different questionnaires
There was a moderate to strong correlation between MFIS and FSS values in the whole cohort and in all subgroups except for the PLMD/RLS subgroup.
There was a moderate correlation between MFIS and PSQI in the whole cohort and in SRBD patients (treated and untreated) and in patients without sleep disorders or with narcolepsy/hypersomnia/MS (but not in PLMD/RLS patients nor insomnia patients).
There was a moderate correlation between FSS and PSQI in SRBD patients (treated and untreated). correlations between patient age and questionnaires
Higher age was related to increased PSQI values in PLMD/ RLS patients and with increased ESS values in patients with narcolepsy/hypersomnia/MS (Table 3) .
correlation between polysomnographic data and questionnaires
With respect to polysomnographic data, a low correlation could be found between increased AHI and lower minimal desaturation on the one hand and increased PSQI values on the other in treated SRBD patients.
Furthermore, there was a low correlation between the number of awakenings and PSQI in all patients and untreated SRBD patients. Similarly, there was a low correlation between an increased arousal index and higher PSQI values in treated SRBD and insomnia patients. In the subgroup without sleep disorders, we did find a moderate nonparametric correlation between increased deep sleep (NREM-3/4) and higher MFIS and FSS values and, similarly, between deep sleep and MFIS in PLMD/RLS patients.
In PLMD/RLS patients, lower sleep latency was correlated with increased ESS values. In insomnia patients, higher FSS values were correlated with increased sleep latency.
Univariate and multiple logistic regressions
We introduced the dichotomous variable "MFIS higher than MFIS mean (34.2)" (yes or no) and the dichotomous variable "FSS higher than FSS mean (4.0)" (yes or no) in order to calculate a multiple logistic regression.
The univariate logistic regression showed no significant relationship with SpO2% min, sleep efficacy, sleep latency, or deep sleep. A significant relationship could be found with age, sex, and number of awakenings for MFIS as well as FSS (Table 4) . Furthermore, there was a significant relationship with arousal index and AHI only for FSS.
The multiple logistic regression (Table 4) investigating the FSS, including age, sex, arousal index, number of awakenings, and AHI, demonstrated a significant relationship with age, sex, and arousal index, whereas AHI and number of awakenings were not significant. Younger age, female sex, and high arousal index were highly predictive of increased FSS scores.
In regards to MFIS, the multiple logistic regression (Table 4) 
Discussion
This is the first study, to our knowledge, to investigate the relationship between sleep disorders and MFIS values, and we observed a number of important findings.
Firstly, this study clearly shows that sleep disorders can lead to high MFIS values in sleep-disordered patients who are not suffering from MS.
Secondly, our results show both high MFIS and FSS values in sleep-disordered patients without MS and, above all, a strong correlation between MFIS and FSS for all patients and all subgroups except for PLMD/RLS patients. (The fact that this correlation could not be demonstrated in PLMD/ RLS patients could be due to small sample size).
Thirdly, the correlation between PSQI and MFIS values in all patients (except for PLMD/RLS and insomnia patients) and between PSQI and FSS in SRBD patients, suggests causation of fatigue by sleep disorders (the lack of correlation in some subgroups may be caused by small sample size). This could be confirmed by multiple logistic regressions, showing that a high number of awakenings were in line with a higher risk of developing fatigue measured with the MFIS and that a high arousal index increased the risk of developing fatigue measured with the FSS. This possible causative role of awakenings and arousals in the pathophysiology of fatigue is of particular interest, and further studies should be performed to elucidate its etiology.
Guilleminault et al used cyclic alternating pattern (CAP) to investigate the relationship between sleep instability and fatigue in patients with upper airway resistance syndrome (UARS) compared with healthy controls. 32 They found higher arousal indexes and sleep disturbances measured with CAP analysis in patients with UARS that correlated with sleepiness and fatigue.
Feige et al summarized the hyperarousal concept in their review about sleep microstructural differences in chronic insomnia. 33 They recommended spectral analysis of the 35 and spontaneous movement arousals in untreated OSAS patients. It is worth noting that previous studies have not shown a significant association between the severity of OSAS (AHI, SpO2% min) and fatigue scores. 36, 37 In our study, there was also no significant relationship between fatigue and AHI or SpO2% min after multiple logistic regressions.
Previous polysomnographic investigations of consecutive MS patients showed a significant association of sleep disorders with fatigue (FSS/MFIS), 22 but not with sleepiness (ESS). Supporting this finding, the works by Hossain et al 19 and Aguillard et al 21 showed that, in sleep-disordered patients without MS, fatigue and sleepiness can occur independently as well as together.
In the present study, there was not a significant relationship between MFIS values and ESS values (only untreated SRBD patients showed a low correlation between ESS values and MFIS). The fact that we found a strong correlation between ESS values and FSS values in patients without sleep disorders remains without explanation. We have to note that these patients were not healthy controls, but rather fatigued and sleepy patients without pathological findings either in the primary health care setting or in the sleep laboratory.
Overall, as we performed multiple logistic regressions only for MFIS and FSS values, we cannot interpret the correlations between ESS and PSQI values and age or sex or polysomnographic parameters. Our study was focused on the relationship between sleep disorders and FSS and MFIS.
In our study, women had a higher risk of suffering from fatigue than men. Our results are in line with a previous study, 17 suggesting that, in SRBD patients, fatigue may be particularly correlated with female sex: in our study, female sex was predictive of high FSS and MFIS values. Currently, we have no explanation for this relationship and further studies are needed to investigate the pathophysiological mechanisms. Similarly, we have no explanation for the fact 
1493
Fatigue in patients with sleep disorders that younger age is predictive of fatigue and further studies are needed to understand this relationship as well. The present study has some methodological limitations: due to the retrospective design and owing to the lack of exclusion criteria, we cannot exclude that some patients have other reasons for fatigue as a possible confounder. On the other hand, this study reflects the daily clinical praxis with consecutive patients over 1 year.
Conclusion
Younger age, female sex, and high number of awakenings and arousals are predictive of fatigue in sleep-disordered patients. Further investigations are needed to find the pathophysiological link for this relationship. This study proves that high MFIS and FSS values can occur in sleep-disordered patients.
